An experimental University of Oxford COVID-19 vaccine (called ChAdOx1 nCoV-19 vaccine) will reportedly immunize people from COVID-19 after two doses. The vaccine been given a passing grade in a 7.20 report by The Lancet. The word is that a million doses could be manufactured by next month, and that general distribution may happen by year’s end or certainly by early ’21.
![](/images/column/Labor20/doses.jpg)
![](/images/column/Labor20/oxfordvax.jpg)
![](https://hollywood-elsewhere.com/wp-content/themes/amory/patreon-banner.jpg)